Delivery Order SPE2DB20D3303-SPE2DB25FA0LM
Award Date 6/18/25
Potential Completion Date 7/11/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,341.80 by the Defense Logistics Agency (DLA) for ProQuad vials, a vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,543.30 by the Defense Logistics Agency (DLA) for ProQuad vials on May 6, 2025, with an ultimate completion date of May 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's Conshohocken facility. ProQuad is a combination vaccine used for immunization against...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,687.48 by the Defense Logistics Agency on September 11, 2025, for the supply of ProQuad vials. This non-competitive, firm fixed-price delivery order is expected to be completed by October 2, 2025, with performance taking place at the vendor's Conshohocken facility. The award represents a child contract issued under AmerisourceBergen's larger...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,792.70 for ProQuad vials by the Defense Logistics Agency on January 22, 2026. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of February 12, 2026. This delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $1,687.48 for ProQuad vials. This contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 through December 2026. The award was issued on August 19, 2025, with an ultimate completion date of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $7,862.80 delivery order from the Defense Logistics Agency on December 19, 2025, for ProQuad vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance taking place at the contractor's Conshohocken facility. The award carries no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on June 2, 2025, for ProQuad vials with a ceiling value of $2,740.40. This firm fixed price contract, with an ultimate completion date of June 24, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,813.98 by the Defense Logistics Agency (DLA) on December 16, 2025, for ProQuad vials with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract awarded through open competition. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,055.26 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of ProQuad vials. The contract features firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by September 23, 2025, at the vendor's Conshohocken facility. This delivery order operates as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 29, 2025, for ProQuad vials with a ceiling value of $50,127. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 22, 2025. The delivery order is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This award falls under...